Pain Management
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who planned painless colonoscopy; (2) Aged from 18 to 65 years; (3) The American Society of Anesthesiologists (ASA) physical status I and II, no serious cardiopulmonary disease, normal liver and kidney function, no mental disease; (4) Body mass index (BMI) was 18-28kg/m2; (5) All patients signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Unaccompanied or guardian; (2) Uncontrolled severe hypertension, severe arrhythmia and unstable angina pectoris; (3) Liver dysfunction (child-pugh grade C or above); (4) Severe renal dysfunction (Cr clearance < 30 ml/min); (5) Those who are unable to communicate with abnormal hearing and vision; (6) Diseases of the neuromuscular system; (7) Drug allergy or other contraindications; (8) Participated in additional drug clinical trials within the past 30 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The total induction dose of propofol ;postoperative pain;Anesthesia induction time;awakening time;Time of departure from the hospital ;The incidence of adverse reactions;postoperative recovery quality; | — |
Secondary
| Measure | Time frame |
|---|---|
| Oxygen saturation;heart rate;mean arterial pressure; | — |
Countries
China
Contacts
Graduate School of Jinzhou University of Medicine